Aimeike: Seize industry development opportunities to strengthen capabilities, build diverse platforms, and enhance brand competitiveness.

robot
Abstract generation in progress

Investors’ Question:

In my opinion, the previous high profitability of the aesthetic medicine industry was mainly due to limited supply of compliant products and relatively closed information for consumers. However, in recent years, the supply of compliant products has greatly increased, and patients have more access to information. Both factors are changing. How does the company plan to enhance its image perception among consumers and build its own differentiated profile under these circumstances, so as to obtain a unique, barrier-protected brand value in product pricing (similar to Moutai, Apple, Gree), rather than relying on previous industry characteristics and industry dividends, and to achieve long-term excess profits based on this advantage? Thank you!

Secretary’s Response ( Aimeike SZ300896 ):

Dear investor, hello. The increase in industry supply and the improvement in information transparency are important features of the transition of the aesthetic medicine industry from rapid growth to high-quality development. The company takes high-quality development as an opportunity to strengthen its professional support capabilities for doctors, doctors’ technical service capabilities for users, the service and保障 capabilities of channels and brands for customers, as well as product quality control and supply chain delivery capabilities.

The company conducts brand building through various platforms such as doctor training platforms, academic promotion activities, and public welfare projects. The “Quanxuan Classroom” training platform has served over 30,000 certified doctors and built an academic resource library with more than 2,000 content items. This professional empowerment system has become a competitive moat that is difficult to replicate. At the same time, the company坚持以专业赋能和社会责任夯实品牌公信力,打造有温度、有价值的责任品牌,强化市场认可度与用户粘性。Thank you for your attention.

See more secretary Q&A>>

Disclaimer: This information is excerpted by Sina Finance from public sources and does not constitute any investment advice; Sina Finance does not guarantee the accuracy of the data, and the content is for reference only.

Massive information, precise interpretation, all in Sina Finance APP

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin